United States Pharmaceuticals

VistaGen Therapeutics Inc (VTGN)

Track

VistaGen Therapeutics Inc. has recorded no insider trading activity within the last 90 days. The most recent transaction occurred on August 7, 2023, involving a purchase by Commodore Capital LP. Prior to this, various executives and entities engaged in buying and selling activity between 2017 and 2022.
Ticker: VTGN Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for VistaGen Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Buy 7 Aug 2023
Value US$2,628,735.18 | Price 323.13 | Shares 51,236 (-16.8%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-08-09 2023-08-07 B Purchase
1.9
COMMODORE CAPITAL LP
Large shareholder
51,236 -16.8%
323.13
US$2,628,735 		51,236 -16.8% 323.13 US$2,628,735
2022-08-22 2022-08-18 B Purchase
1.3
GIN JERRY B
Non-Executive Director
33,474 +43.2%
463.95
US$3,176,657 		33,474 +43.2% 463.95 US$3,176,657
2022-08-22 2022-08-18 B Purchase
1.3
GIN JERRY B
Non-Executive Director
16,941 -37.0%
148.97
US$2,016,797 		16,941 -37.0% 148.97 US$2,016,797
2022-08-19 2022-08-17 B Purchase
1.6
Adler Reid G.

CHIEF LEGAL OFFICER

Officer
300,000 +866.3%
0.17
US$50,910 		300,000 +866.3% 0.17 US$50,910
2022-08-18 2022-08-17 B Purchase
1.5
Singh Shawn

CHIEF EXECUTIVE OFFICER

Executive Director
600,000 +2287.1%
0.17
US$103,200 		600,000 +2287.1% 0.17 US$103,200
2022-07-14 2022-07-12 S Sale
3.0
Venrock Healthcare Capital Partners II, L.P.
Large shareholder
60,000 -0.3%
0.89
US$53,400 		60,000 -0.3% 0.89 US$53,400
2020-08-24 2020-08-21 B Purchase
3.1
SAXE JON S
Non-Executive Director
30,000 +150.0%
0.69
US$20,700 		30,000 +150.0% 0.69 US$20,700
2019-11-21 2019-11-20 B Purchase SNODGRASS H. RALPH

PRES./CHIEF SCIENTIFIC OFFICER
15,000 +inf%
0.34
US$5,100 		15,000 +inf% 0.34 US$5,100
2019-03-14 2019-03-14 B Purchase
3.1
SAXE JON S
7,920 +65.6%
1.27
US$10,086 		7,920 +65.6% 1.27 US$10,086
2019-03-14 2019-03-13 B Purchase
3.1
SAXE JON S
12,080 +inf%
1.26
US$15,201 		12,080 +inf% 1.26 US$15,201
2017-06-01 2017-05-31 B Purchase GIN JERRY B
50,000
0.00
US$0 		50,000 0.00 US$0
2017-06-01 2017-05-31 B Purchase GIN JERRY B
50,000
0.00
US$0 		50,000 0.00 US$0
Explore more

More insider trading research around VistaGen Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America